Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haimiao Yang

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Pharmacology|June 21, 2021
Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male VolunteersYingzi Cui, Dongyang Cui, Xinran Ren, et al.
Frontiers in Pharmacology|May 23, 2022
Corrigendum: Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta<sup>®</sup> in Healthy Chinese Male VolunteersYingzi Cui, Dongyang Cui, Xinran Ren, et al.
Frontiers in Pharmacology|June 16, 2025
The food effect on the pharmacokinetics of TQB3616 capsule in Chinse healthy subjects: a randomized, open-label, single-center, two-period, two-sequence crossover phase I clinical trialJun Dai, Yanan Zhou, Lei Zhang, et al.
World Journal of Microbiology & Biotechnology|November 27, 2021
Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infectionJiaxuan Feng, Dazhong Sun, Li Wang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 13, 2018
The Efficacy and Safety of Shen Guo Lao Nian Granule for Common Cold of Qi-Deficiency Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II Clinical TrialXuemei Liu, Juanjuan Fu, Tao Fan, et al.
Microbiology Spectrum|March 23, 2022
Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal PneumoniaShisong Jing, Xiangri Kong, Li Wang, et al.
Frontiers in Pharmacology|October 24, 2022
Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial statesXinyao Qu, Qiaohuan Deng, Ying Li, et al.
ACS Applied Materials & Interfaces|June 21, 2021
Improved Antiviral Activity of Classical Swine Fever Virus-Targeted siRNA by Tetrahedral Framework Nucleic Acid-Enhanced DeliveryHaisi Dong, Guangqi Song, Danhui Ma, et al.
Expert Opinion on Biological Therapy|October 5, 2021
A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjectsGuangwen Liu, Zhongnan Xu, Wei Yang, et al.
Expert Opinion on Investigational Drugs|February 9, 2023
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjectsYanli Wang, Jinling Xue, Zhengjie Su, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|June 21, 2021
Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male VolunteersYingzi Cui, Dongyang Cui, Xinran Ren, et al.
Frontiers in Pharmacology|May 23, 2022
Corrigendum: Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta<sup>®</sup> in Healthy Chinese Male VolunteersYingzi Cui, Dongyang Cui, Xinran Ren, et al.
Frontiers in Pharmacology|June 16, 2025
The food effect on the pharmacokinetics of TQB3616 capsule in Chinse healthy subjects: a randomized, open-label, single-center, two-period, two-sequence crossover phase I clinical trialJun Dai, Yanan Zhou, Lei Zhang, et al.
World Journal of Microbiology & Biotechnology|November 27, 2021
Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infectionJiaxuan Feng, Dazhong Sun, Li Wang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 13, 2018
The Efficacy and Safety of Shen Guo Lao Nian Granule for Common Cold of Qi-Deficiency Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II Clinical TrialXuemei Liu, Juanjuan Fu, Tao Fan, et al.
Microbiology Spectrum|March 23, 2022
Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal PneumoniaShisong Jing, Xiangri Kong, Li Wang, et al.
Frontiers in Pharmacology|October 24, 2022
Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial statesXinyao Qu, Qiaohuan Deng, Ying Li, et al.
ACS Applied Materials & Interfaces|June 21, 2021
Improved Antiviral Activity of Classical Swine Fever Virus-Targeted siRNA by Tetrahedral Framework Nucleic Acid-Enhanced DeliveryHaisi Dong, Guangqi Song, Danhui Ma, et al.
Expert Opinion on Biological Therapy|October 5, 2021
A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjectsGuangwen Liu, Zhongnan Xu, Wei Yang, et al.
Expert Opinion on Investigational Drugs|February 9, 2023
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjectsYanli Wang, Jinling Xue, Zhengjie Su, et al.
Pageof 3